2012: The year in review. Part II: Tuberculosis and lung disease

International Journal of Tuberculosis and Lung Disease

Volumn 17, Issue 9, 2013, Pages 1151-1159

  Leung, C C ^a  

^a DEPARTMENT OF HEALTH   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; ETHIONAMIDE; ISONIAZID; ISONIAZID PLUS RIFAMPICIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAPENTINE; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ANEMIA; ASTHMA; ATYPICAL MYCOBACTERIOSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG FEVER; DRUG HYPERSENSITIVITY; EDEMA; EOSINOPHILIA; ETHNICITY; FEVER; GENE FREQUENCY; GENETIC POLYMORPHISM; GEOGRAPHIC DISTRIBUTION; HEPATITIS; HUMAN; INFECTION RATE; INFECTION RISK; LATENT TUBERCULOSIS; LUNG DISEASE; LUNG FUNCTION; LUNG LAVAGE; LUNG TUBERCULOSIS; MULTIDETECTOR COMPUTED TOMOGRAPHY; MYCOBACTERIUM AFRICANUM; MYCOBACTERIUM TUBERCULOSIS; NIGHT SWEAT; PERIPHERAL NEUROPATHY; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PRURITUS; RASH; REVIEW; RISK ASSESSMENT; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SMOKING; SPUTUM ANALYSIS; THORAX RADIOGRAPHY; TREATMENT REFUSAL; TUBERCULOSIS CONTROL; WEIGHT REDUCTION;

EID: 84882963172     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.13.0385     Document Type: Review

References (104)

1. Isea-Peña M C, Brezmes-Valdivieso M F, González-Velasco M C, et al. Mycobacterium africanum, an emerging disease in high-income countries? Int J Tuberc Lung Dis 2012; 16: 1400-1404.
2. Adesokan H K, Jenkins A O, van Soolingen D, Cadmus S I B. Mycobacterium bovis infection in livestock workers in Ibadan, Nigeria: evidence of occupational exposure. Int J Tuberc Lung Dis 2012; 16: 1388-1392.
3. Rio Mycobacterium tuberculosis is not associated with differential clinical features. Int J Tuberc Lung Dis 2012; 16: 1377-1382.
4. Sasmono R T, Massi M N, Setianingsih T Y, et al. Heterogeneity of Mycobacterium tuberculosis strains in Makassar, Indonesia. Int J Tuberc Lung Dis 2012; 16: 1441-1448.
5. Mor Z, Pinsker G, Cedar N, Lidji M, Grotto I. Adult tuberculosis in Israel and migration: trends and challenges between 1999. and 2010. Int J Tuberc Lung Dis 2012; 16: 1613-1618.
6. Shah N S, Cavanaugh J S, Pratt R, et al. Epidemiology of smear-negative pulmonary tuberculosis in the United States, 1993-2008. Int J Tuberc Lung Dis 2012; 16: 1234-1240.
7. Chakrabarti S, Saha I, Das D K, Prasad Sarkar A, Roy R, Hossain A. Comparative study of the profiles of tribal and nontribal tuberculosis patients in a tuberculosis unit of West Bengal, India. Int J Tuberc Lung Dis 2012; 16: 1205-1209.
8. Middelkoop K, Bekker L-G, Shashkina E, Kreiswirth B, Wood R. Retreatment tuberculosis in a South African community: the role of re-infection, HIV and antiretroviral treatment. Int J Tuberc Lung Dis 2012; 16: 1510-1516.
9. Zetola N M, Modongo C, Kip E C, Gross R, Bisson G P, Collman R G. Alcohol use and abuse among patients with multidrug-resistant tuberculosis in Botswana. Int J Tuberc Lung Dis 2012; 16: 1529-1534.
10. Faurholt-Jepsen D, Range N, Pray God G, et al. The role of anthropometric and other predictors for diabetes among urban Tanzanians with tuberculosis. Int J Tuberc Lung Dis 2012; 16: 1680-1685.
11. Conesa-Botella A, Goovaerts O, Massinga-Loembé M, et al. Low prevalence of vitamin D deficiency in Ugandan HIVinfected patients with and without tuberculosis. Int J Tuberc Lung Dis 2012; 16: 1517-1521.
12. Rathored J, Sharma S K, Singh B, et al. Risk and outcome of multidrug-resistant tuberculosis: vitamin D receptor polymorphisms and serum 25(OH)D. Int J Tuberc Lung Dis 2012; 16: 1522-1528.
13. Alavi-Naini R, Salimi S, Sharifi-Mood B, Davoodikia A A, Moody B, Naghavi A. Association between the CD14 gene C-159T polymorphism and serum soluble CD14 with pulmonary tuberculosis. Int J Tuberc Lung Dis 2012; 16: 1383-1387.
14. Vu D H, van Rein N, Cobelens F G J, Nguyen T T H, Le V H, Brouwers J R B J. Suspected tuberculosis case detection and referral in private pharmacies in Viet Nam. Int J Tuberc Lung Dis 2012; 16: 1625-1629.
15. Salinas J, Calvillo S, Caylà J, Nedel F B, Martín M, Navarro A. Delays in the diagnosis of pulmonary tuberculosis in Coahuila, Mexico. Int J Tuberc Lung Dis 2012; 16: 1193-1198.
16. Zhou C, Tobe R G, Chu J, Gen H, Wang X, Xu L. Detection delay of pulmonary tuberculosis patients among migrants in China: a cross-sectional study. Int J Tuberc Lung Dis 2012; 16: 1630-1636.
17. Thind D, Charalambous S, Tongman A, Churchyard G, Grant A D. An evaluation of 'Ribolola': a household tuberculosis contact tracing programme in North West Province, South Africa. Int J Tuberc Lung Dis 2012; 16: 1643-1648.
18. Bhushan B, Kajal N C, Maske A, Singh S P. Manifestations of tuberculosis in elderly versus young hospitalised patients in Amritsar, India. Int J Tuberc Lung Dis 2012; 16: 1210-1213.
19. Hanifa Y, Fielding K L, Charalambous S, et al. Tuberculosis among adults starting antiretroviral therapy in South Africa: the need for routine case finding. Int J Tuberc Lung Dis 2012; 16: 1252-1259.
20. Story A, Aldridge R W, Abubakar I, et al. Active case finding for pulmonary tuberculosis using mobile digital chest radiography: an observational study. Int J Tuberc Lung Dis 2012; 16: 1461-1467.
21. Okada K, Onozaki I, Yamada N, et al. Epidemiological impact of mass tuberculosis screening: a 2-year follow-up after a national prevalence survey. Int J Tuberc Lung Dis 2012; 16: 1619-1624.
22. Alvarez G G, Sabri E, Ling D, Cameron D W, Maartens G, Wilson D. A model to rule out smear-negative tuberculosis among symptomatic HIV patients using C-reactive protein. Int J Tuberc Lung Dis 2012; 16: 1247-1251.
23. Li H, Yang L, Zheng C-Y, Wang J, Abdullah A S. Use of bronchoalveolar lavage enzyme-linked immunospot for diagnosis of smear-negative pulmonary tuberculosis. Int J Tuberc Lung Dis 2012; 16: 1668-1673.
24. Chen J, Yang Z-G, Shao H, et al. Differentiation of tuberculosis from lymphomas in neck lymph nodes with multidetectorrow computed tomography. Int J Tuberc Lung Dis 2012; 16: 1686-1691.
25. Martinez V, Castilla-Lievre M A, Guillet-Caruba C, et al. 18F-FDG PET/CT in tuberculosis: an early non-invasive marker of therapeutic response. Int J Tuberc Lung Dis 2012; 16: 1180-1185.
26. Lawn S D, Kerkhoff A D, Pahlana P, Vogt M, Wood R. Diagnostic yield of tuberculosis using sputum induction in HIVpositive patients before antiretroviral therapy. Int J Tuberc Lung Dis 2012; 16: 1354-1357.
27. Van Deun A, Maug A K J, Hossain A, Gumusboga M, de Jong B C. Fluorescein diacetate vital staining allows earlier diagnosis of rifampicin-resistant tuberculosis. Int J Tuberc Lung Dis 2012; 16: 1174-1179.
28. Shin S S, Asencios L, Yagui M, et al. Impact of rapid drug susceptibility testing for tuberculosis: program experience in Lima, Peru. Int J Tuberc Lung Dis 2012; 16: 1538-1543.
29. David S, Sutre A F, Sanca A, et al. Tuberculosis diagnosis after bleach processing for early stage tuberculosis laboratory capacity building. Int J Tuberc Lung Dis 2012; 16: 1535-1537.
30. Chou P-C, Wang C-H, Huang C-D, et al. Nucleic acid amplification test and bronchoscopy improve the diagnostic accuracy of smear-negative tuberculosis. Int J Tuberc Lung Dis 2012; 16: 1674-1679.
31. Ntinginya E N, Squire S B, Millington K A, et al. Performance of the Xpert® MTB/RIF assay in an active case-finding strategy: a pilot study from Tanzania. Int J Tuberc Lung Dis 2012; 16: 1468-1470.
32. Balcells M E, García P, Chanqueo L, et al. Rapid molecular detection of pulmonary tuberculosis in HIV-infected patients in Santiago, Chile. Int J Tuberc Lung Dis 2012; 16: 1349-1353.
33. Kim S Y, Kim H, Kim S Y, et al. The Xpert® MTB/RIF assay evaluation in South Korea, a country with an intermediate tuberculosis burden. Int J Tuberc Lung Dis 2012; 16: 1471-1476.
34. Mitchison D A. Pharmacokinetic/pharmacodynamic parameters and the choice of high-dosage rifamycins. Int J Tuberc Lung Dis 2012; 16: 1186-1189.
35. Sharma S K, Solanki R, Mohan A, Jain N K, Chauhan L S, Pleural Effusion Study Group. Outcomes of Category III DOTS treatment in immunocompetent patients with tuberculosis pleural effusion. Int J Tuberc Lung Dis 2012; 16: 1505-1509.
36. Hou W-L, Song F-J, Zhang N-X, et al. Implementation and community involvement in DOTS strategy: a systematic review of studies in China. Int J Tuberc Lung Dis 2012; 16: 1433-1440.
37. Au-Yeung K Y, DiCarlo L. Cost comparison of wirelessly vs. directly observed therapy for adherence confirmation in antituberculosis treatment. Int J Tuberc Lung Dis 2012; 16: 1498-1504.
38. Kizub D, Ghali I, Sabouni R, et al. Qualitative study of perceived causes of tuberculosis treatment default among health care workers in Morocco. Int J Tuberc Lung Dis 2012; 16: 1214-1220.
39. Puchalski Ritchie L M, van Lettow M, Barnsley J, et al. Evaluation of lay health workers' needs to effectively support antituberculosis treatment adherence in Malawi. Int J Tuberc Lung Dis 2012; 16: 1492-1497.
40. Zafar Ullah A N, Huque R, Husain A, Akter S, Akter H, Newell J N. Tuberculosis in the workplace: developing partnerships with the garment industries in Bangladesh. Int J Tuberc Lung Dis 2012; 16: 1637-1642.
41. Deng R, Yang T, Wang Y, Tang N. CYP2E1 RsaI/PstI polymorphism and risk of anti-tuberculosis drug-induced liver injury: a meta-analysis. Int J Tuberc Lung Dis 2012; 16: 1574-1581.
42. Miwa S, Suzuki Y, Shirai M, et al. Drug lymphocyte stimulation test is not useful for side effects of anti-tuberculosis drugs despite its timing. Int J Tuberc Lung Dis 2012; 16: 1265-1269.
43. Lehloenya R J, Wallace J, Todd G, Dheda K. Multiple drug hypersensitivity reactions to anti-tuberculosis drugs: five cases in HIV-infected patients. Int J Tuberc Lung Dis 2012; 16: 1260-1264.
44. Takuva S, Westreich D, Menezes C N, et al. Antiretroviral therapy initiation during tuberculosis treatment and HIV-RNA and CD4 T-lymphocyte responses. Int J Tuberc Lung Dis 2012; 16: 1358-1364.
45. Breton G, Bourgarit A, Pavy S, et al. Treatment for tuberculosisassociated immune reconstitution inflammatory syndrome in 34 HIV-infected patients. Int J Tuberc Lung Dis 2012; 16: 1365-1370.
46. Lee J, Lee B J, Yoon H I, Lee C-T, Lee J H. Influence of previous tuberculosis treatment history on acid-fast bacilli smear and culture conversion. Int J Tuberc Lung Dis 2012; 16: 1344-1348.
47. van der Kuyp F, Mahan C S. Prolonged positivity of sputum smears with negative cultures during treatment for pulmonary tuberculosis. Int J Tuberc Lung Dis 2012; 16: 1663-1667.
48. van der Heijden Y F, Maruri F, Blackman A, et al. Fluoroquinolone exposure prior to tuberculosis diagnosis is associated with an increased risk of death. Int J Tuberc Lung Dis 2012; 16: 1162-1167.
49. Kattan J A, Sosa L E, Lobato M N. Tuberculosis mortality: death from a curable disease, Connecticut, 2007-2009. Int J Tuberc Lung Dis 2012; 16: 1657-1662.
50. Henegar C, Behets F, Vanden Driessche K, et al. Mortality among tuberculosis patients in the Democratic Republic of Congo. Int J Tuberc Lung Dis 2012; 16: 1199-1204.
51. Nansera D, Bajunirwe F, Elyanu P, Asiimwe C, Amanyire G, Graziano F M. Mortality and loss to follow-up among tuberculosis and HIV co-infected patients in rural southwestern Uganda. Int J Tuberc Lung Dis 2012; 16: 1371-1376.
52. van't Hoog A H, Williamson J, Sewe M, et al. Risk factors for excess mortality and death in adults with tuberculosis in Western Kenya. Int J Tuberc Lung Dis 2012; 16: 1649-1656.
53. Gler M T, Guilatco R S, Guray C V, Tupasi T E. Screening outcomes from patients with suspected multidrug-resistant tuberculosis: lessons learned in the Philippines. Int J Tuberc Lung Dis 2012; 16: 1326-1330.
54. Althomsons S P, Cegielski J P. Impact of second-line drug resistance on tuberculosis treatment outcomes in the United States: MDR-TB is bad enough. Int J Tuberc Lung Dis 2012; 16: 1331-1334.
55. Kurbatova E V, Gammino V M, Bayona J, et al. Predictors of sputum culture conversion among patients treated for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2012; 16: 1335-1343.
56. Blöndal K, Viiklepp P, Gu{eth}mundsson L J, Altraja A. Predictors of recurrence of multidrug-resistant and extensively drugresistant tuberculosis. Int J Tuberc Lung Dis 2012; 16: 1228-1233.
57. Rose P C, Hallbauer U M, Seddon J A, Hesseling A C, Schaaf H S. Linezolid-containing regimens for the treatment of drugresistant tuberculosis in South African children. Int J Tuberc Lung Dis 2012; 16: 1588-1593.
58. Hong S-J, Park Y-S, An H, Kang S-M, Cho E-H, Shin S-S. Factors leading to under-reporting of tuberculosis in the private sector in Korea. Int J Tuberc Lung Dis 2012; 16: 1221-1227.
59. Sonnenberg P, Lim M S C, Dowdeswell R J, Field N, Glynn J R, Murray J. Quantifying errors in the estimation of tuberculosis mortality in a population of South African miners. Int J Tuberc Lung Dis 2012; 16: 1449-1454.
60. Pray God G, Todd J, McDermid J M. Early childhood tuberculosis in northwestern Tanzania. Int J Tuberc Lung Dis 2012; 16: 1455-1460.
61. Gardner A, Naureckas C, Beckwith C, Losikoff P, Martin C, Carter E J. Experiences in implementation of routine human immunodeficiency virus testing in a US tuberculosis clinic. Int J Tuberc Lung Dis 2012; 16: 1241-1246.
62. Naidoo S, Seevnarain K, Nordstrom D L. Tuberculosis infection control in primary health clinics in eThekwini, Kwa Zulu-Natal, South Africa. Int J Tuberc Lung Dis 2012; 16: 1600-1604.
63. Reid M J A, Saito S, Nash D, Scardigli A, Casalini C, Howard A A. Implementation of tuberculosis infection control measures at HIV care and treatment sites in sub-Saharan Africa. Int J Tuberc Lung Dis 2012; 16: 1605-1612.
64. Kolappan C, Subramani R, Chandrasekaran V, Thomas A. Trend in tuberculosis infection prevalence in a rural area in South India after implementation of the DOTS strategy. Int J Tuberc Lung Dis 2012; 16: 1315-1319.
65. He G X, Wang L X, Chai S J, et al. Risk factors associated with tuberculosis infection among health care workers in Inner Mongolia, China. Int J Tuberc Lung Dis 2012; 16: 1485-1491.
66. Higuchi K, Sekiya Y, Igari H, Watanabe A, Harada N. Comparison of specificities between two interferon-gamma release assays in Japan. Int J Tuberc Lung Dis 2012; 16: 1190-1192.
67. Rutherford M E, Hill P C, Maharani W, et al. Risk factors for Mycobacterium tuberculosis infection in Indonesian children living with a sputum smear-positive case. Int J Tuberc Lung Dis 2012; 16: 1594-1599.
68. Lohmann E M, Koster B F P J, le Cessie S, Kamst-van Agterveld M P, van Soolingen D, Arend S M. Grading of a positive sputum smear and the risk of Mycobacterium tuberculosis transmission. Int J Tuberc Lung Dis 2012; 16: 1477-1484.
69. Smith M Y, Attig B, McNamee L, Eagle T. Tuberculosis screening in prescribers of anti-tumor necrosis factor therapy in the European Union. Int J Tuberc Lung Dis 2012; 16: 1168-1173.
70. Jung Y J, Lyu J, Yoo B, et al. Combined use of a TST and the T-SPOT®.TB assay for latent tuberculosis infection diagnosis before anti-TNF-α treatment. Int J Tuberc Lung Dis 2012; 16: 1300-1306.
71. Saidenberg-Kermanac'h N, Semerano L, Naccache J M, et al. Screening for latent tuberculosis in anti-TNF-α candidate patients in a high tuberculosis incidence setting. Int J Tuberc Lung Dis 2012; 16: 1307-1314.
72. Denholm J T, Leslie D E, Jenkin G A, et al. Long-term followup of contacts exposed to multidrug-resistant tuberculosis in Victoria, Australia, 1995-2010. Int J Tuberc Lung Dis 2012; 16: 1320-1325.
73. Kim S-Y, Lee S-T, Jeong B-H, et al. Clinical significance of mycobacterial genotyping in Mycobacterium avium lung disease in Korea. Int J Tuberc Lung Dis 2012; 16: 1393-1399.
74. Huang C-T, Tsai Y-J, Wu H-D, et al. Impact of non-tuberculous mycobacteria on pulmonary function decline in chronic obstructive pulmonary disease. Int J Tuberc Lung Dis 2012; 16: 539-545.
75. Paulson M L, Olivier K N, Holland S M. Pulmonary nontuberculous mycobacterial infection in congenital contractural arachnodactyly. Int J Tuberc Lung Dis 2012; 16: 561-563.
76. Seung K J, Rigodon J, Finch M, Gove S, Vasan A, Satti H. Distribution of adult respiratory illnesses at a primary health centre in Lesotho. Int J Tuberc Lung Dis 2012; 16: 418-422.
77. Masekela R, Anderson R, Moodley T, et al. HIV-related bronchiectasis in children: an emerging spectre in high tuberculosis burden areas. Int J Tuberc Lung Dis 2012; 16: 114-119.
78. Commons R J, Denholm J. Triaging pandemic flu: pneumonia severity scores are not the answer. Int J Tuberc Lung Dis 2012; 16: 670-673.
79. Radwan G N, Emam A H, Maher K M, Mehrez M, El-Sayed N, El-Nahas G M. Public opinion on smoke-free policies among Egyptians. Int J Tuberc Lung Dis 2012; 16: 1412-1417.
80. Tee G H, Hairi N N, Hairi F. Attitudes towards smoking and tobacco control among pre-clinical medical students in Malaysia. Int J Tuberc Lung Dis 2012; 16: 1126-1128.
81. Abughosh S, Wu I-H, Peters R J, Hawari F, Essien E J. Ethnicity and waterpipe smoking among US students. Int J Tuberc Lung Dis 2012; 16: 1551-1557.
82. Khabour O F, Alzoubi K H, Eissenberg T, et al. Waterpipe tobacco and cigarette smoking among university students in Jordan. Int J Tuberc Lung Dis 2012; 16: 986-992.
83. Auf R A, Radwan G N, Loffredo C A, El Setouhy M, Israel E, Mohamed M K. Assessment of tobacco dependence in waterpipe smokers in Egypt. Int J Tuberc Lung Dis 2012; 16: 132-137.
84. Shin S S, Xiao D, Cao M, et al. Patient and doctor perspectives on incorporating smoking cessation into tuberculosis care in Beijing, China. Int J Tuberc Lung Dis 2012; 16: 126-131.
85. Jeremias E, Chatkin J M, Chatkin G, Seibert J, Martins M, Wagner M. Smoking cessation in older adults. Int J Tuberc Lung Dis 2012; 16: 273-278.
86. Heydari G, Talischi F, Tafti S F, Masjedi M R. Quitting smoking with varenicline: parallel, randomised efficacy trial in Iran. Int J Tuberc Lung Dis 2012; 16: 268-272.
87. Yasin S M, Moy F M, Retneswari M, Isahak M, Koh D. Timing and risk factors associated with relapse among smokers attempting to quit in Malaysia. Int J Tuberc Lung Dis 2012; 16: 980-985.
88. Tian J, Zhou Y, Cui J, et al. Peak expiratory flow as a screening tool to detect airflow obstruction in a primary health care setting. Int J Tuberc Lung Dis 2012; 16: 674-680.
89. Lam D C L, Fong D Y T, Yu W C, et al. FEV3, FEV6 and their derivatives for detecting airflow obstruction in adult Chinese. Int J Tuberc Lung Dis 2012; 16: 681-686.
90. Jung Y J, Ra S W, Lee S-D, Park C S, Oh Y-M. Clinical features of subjects with an isolated FEV1 reduction. Int J Tuberc Lung Dis 2012; 16: 262-267.
91. Mannino D M, McBurnie M A, Tan W, et al. Restricted spirometry in the Burden of Lung Disease Study. Int J Tuberc Lung Dis 2012; 16: 1405-1411.
92. Ellwood P, Asher M I, Stewart A W, et al. The challenges of replicating the methodology between Phases I and III of the ISAAC programme. Int J Tuberc Lung Dis 2012; 16: 687-693.
93. Jindal S K, Aggarwal A N, Gupta D, et al. Indian Study on Epidemiology of Asthma, Respiratory Symptoms and Chronic Bronchitis in adults (INSEARCH). Int J Tuberc Lung Dis 2012; 16: 1270-1277.
94. Dhabadi B B, Athavale A, Meundi A, et al. Prevalence of asthma and associated factors among schoolchildren in rural South India. Int J Tuberc Lung Dis 2012; 16: 120-125.
95. Miyake Y, Tanaka K, Arakawa M. ADAM33 polymorphisms, smoking and asthma in Japanese women: the Kyushu Okinawa Maternal and Child Health Study. Int J Tuberc Lung Dis 2012; 16: 974-979.
96. Miyake Y, Tanaka K, Okubo H, Sasaki S, Arakawa M. Dairy food, calcium and vitamin D intake and prevalence of allergic disorders in pregnant Japanese women. Int J Tuberc Lung Dis 2012; 16: 255-261.
97. Miyake Y, Tanaka K, Sasaki S, Hirota Y. Parental employment, income, education and allergic disorders in children: a prebirth cohort study in Japan. Int J Tuberc Lung Dis 2012; 16: 756-761.
98. Yoon S Y, Kim T-B, Baek S, et al. The impact of total antioxidant capacity on pulmonary function in asthma patients. Int J Tuberc Lung Dis 2012; 16: 1544-1550.
99. Holm M, Kim J-L, Lillienberg L, et al. Incidence and prevalence of chronic bronchitis: impact of smoking and welding. The RHINE study. Int J Tuberc Lung Dis 2012; 16: 553-557.
100. Sukhsohale N D, Narlawar U W, Ughade S N, Kulkarni H. Even partial reduction of biomass fuel use may improve the respiratory health of rural women in Central India. Int J Tuberc Lung Dis 2012; 16: 423-245.
101. Adair T, Hoy D, Dettrick Z, Lopez A D. 100 years of mortality due to chronic obstructive pulmonary disease in Australia: the role of tobacco consumption. Int J Tuberc Lung Dis 2012; 16: 1699-1705.
102. Bensenor I M, Lotufo P A. Household income, sex and respiratory mortality in São Paulo, Brazil, 1996-2010. Int J Tuberc Lung Dis 2012; 16: 1692-1698.
103. Leung C C, Lam T H, Yew W-W, et al. Obstructive lung disease does not increase lung cancer mortality among female never-smokers in Hong Kong. Int J Tuberc Lung Dis 2012; 16: 546-552.
104. Park B H, Park M S, Chang J, et al. Chronic obstructive pulmonary disease and metabolic syndrome: a nationwide survey in Korea. Int J Tuberc Lung Dis 2012; 16: 694-700.